Atorvastatin (Lipitor): Your Complete Guide to Cholesterol-Lowering Statin Therapy

Atorvastatin (brand name Lipitor) is a HMG-CoA reductase inhibitor — commonly called a 'statin' — that reduces the liver's production of LDL (low-density lipoprotein) cholesterol, often called 'bad cholesterol'. It also modestly increases HDL ('good cholesterol') and reduces triglycerides. Multiple large clinical trials (including the landmark ASCOT-LLA trial) have proven that atorvastatin significantly reduces the risk of heart attacks, strokes, and cardiovascular death in high-risk patients.

Atorvastatin is prescribed for two main indications: primary prevention (reducing risk in high-risk patients without established cardiovascular disease, such as those with diabetes, hypertension, or very high cholesterol) and secondary prevention (after a heart attack, stroke, or other atherosclerotic cardiovascular event — in this case, high-dose atorvastatin 40–80mg is standard). In Korea, atorvastatin is widely prescribed by cardiologists and GPs at local clinics and hospitals, and is covered by National Health Insurance (NHIS).

Side effects are generally mild and uncommon. The most clinically significant is myopathy (muscle pain and weakness) — rarely progressing to rhabdomyolysis (severe muscle breakdown). Patients experiencing new or unexplained muscle pain, weakness, or dark urine should stop the medication and contact their doctor. Liver enzyme elevation occurs in a small minority and is checked at baseline and after dose changes. Atorvastatin is taken once daily — the evening is traditionally preferred (as cholesterol synthesis peaks at night) but morning dosing is equally effective and may improve adherence.